Neurogene is looking to make the leap from a clinical biotech to a commercial biopharma with its lead gene therapy and has hired an industry veteran to take the reins.
Pivotal trial of Moderna’s H5N1 bird flu jab gets underway
The first volunteers in a large-scale trial of Moderna’s mRNA-based vaccine against bird flu have received shots in the UK and US.


